Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Finding a Path Forward After the COVID-19 Pandemic

On this episode of Healthcare Analytics Decoded, a Quantros podcast, Quantros’ Lindsey Klein was joined by Dr. Stan Schwartz, noted healthcare consultant, President and CEO of WellOK, the Northeastern Oklahoma Business Coalition on Health, and Chief Medical Officer for The Zero Card, Inc. The Zero Card is a digital health company that connects self-funded…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Finding a Path Forward After the COVID-19 Pandemic

On this episode of Healthcare Analytics Decoded, a Quantros podcast, Quantros’ Lindsey Klein was joined by Dr. Stan Schwartz, noted healthcare consultant, President and CEO of WellOK, the Northeastern Oklahoma Business Coalition on Health, and Chief Medical Officer for The Zero Card, Inc.

The Zero Card is a digital health company that connects self-funded employers to providers willing to provide bundled services, providing a healthcare model that’s easier to understand, simpler to use and avoids the typical mountains of paperwork and bills that make navigating care difficult.

Schwartz labeled the COVID-19 pandemic as a “once in a century” learning experience due to its near “perfect storm” of disruptive factors, such as the rapidity with which it spreads and the lack of a vaccine or treatment.

Schwartz also said that the pandemic could continue fraying the already weakening bonds between patients and consistent primary care physicians, migrate the healthcare system away from being hospital-centric, and raise the volume on the conversation regarding lower cost or free care, which is already being implemented for coronavirus-related care.

Klein and Schwartz said the way forward, then, is increased transparency in healthcare for patients that could reduce the overwhelming nature of information regarding their treatment and care.

Solutions like those provided by Quantros could help patients better define “quality,” finding surgeons and physicians that are truly the best option for their treatment and care.

“Reputation is one thing, but, as we say at The Zero Card, ‘We trust grandma, but everyone else must bring data,” Schwartz said.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

The Centers for Medicare & Medicaid Services (CMS) has established a new Office of Health Technology and Products. This office assumes over 90 responsibilities to lead federal health IT strategy, focusing on areas like AI, interoperability, and claims modernization.

  • 01CMS's new office centralizes health tech authority, focusing on AI and interoperability.
  • 02The office takes on over 90 responsibilities to modernize claims processes.
  • 03CMS aims to lead federal health IT strategy with its new dedicated office.

Aug 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512